Open | $34.690 |
Close | $34.240 |
Volume / Avg. | 762.381K / 620.924K |
Day Range | 34.170 - 34.830 |
52 Wk Range | 33.440 - 59.330 |
Market Cap | $2.678B |
P/E Ratio | 41.310 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 3.68% |
Days to Cover | 4.73 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Integra Lifesciences (NASDAQ: IART) through any online brokerage.
Other companies in Integra Lifesciences’s space includes: Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST), Inari Medical (NASDAQ:NARI), Alphatec Holdings (NASDAQ:ATEC) and NovoCure (NASDAQ:NVCR).
The latest price target for Integra Lifesciences (NASDAQ: IART) was reported by Truist Securities on Friday, March 1, 2024. The analyst firm set a price target for 41.00 expecting IART to rise to within 12 months (a possible 19.74% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Integra Lifesciences (NASDAQ: IART) is $34.24 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Integra Lifesciences.
Integra Lifesciences’s Q1 earnings are confirmed for Wednesday, April 24, 2024.
There is no upcoming split for Integra Lifesciences.
Integra Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.